Jane Street Group, LLC Citius Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 93,446 shares of CTXR stock, worth $242,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,446

Previous 383,530 75.64%

Holding current value

$242,025

Previous $222,000 79.28%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.48 - $1.02 $139,240 - $295,885	-290,084 Reduced 75.64%	93,446 $46,000
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.03 $176,946 - $314,233	305,081 Added 388.89%	383,530 $222,000
Q1 2024 May 15, 2024	SELL	$0.6 - $0.9 $12,146 - $18,219	-20,244 Reduced 20.51%	78,449 $70,000
Q4 2023 Feb 14, 2024	BUY	$0.65 - $0.86 $64,150 - $84,875	98,693 New	98,693 $75,000
Q2 2023 Aug 14, 2023	SELL	$1.08 - $1.65 $188,193 - $287,517	-174,253 Reduced 70.83%	71,770 $86,000
Q1 2023 May 15, 2023	BUY	$0.78 - $1.42 $175,492 - $319,485	224,990 Added 1069.7%	246,023 $287,000
Q4 2022 Feb 14, 2023	SELL	$0.79 - $1.28 $7,569 - $12,264	-9,582 Reduced 31.3%	21,033 $16,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $4,286 - $40,717	30,615 New	30,615 $37,000
Q1 2022 May 17, 2022	SELL	$1.38 - $1.89 $56,557 - $77,459	-40,984 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.51 - $2.2 $61,885 - $90,164	40,984 New	40,984 $63,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $4.23 $83,595 - $234,177	-55,361 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$1.04 - $2.34 $57,575 - $129,544	55,361 New	55,361 $99,000
Q1 2020 May 15, 2020	SELL	$0.46 - $1.3 $5,004 - $14,144	-10,880 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.42 - $1.15 $4,569 - $12,511	10,880 New	10,880 $11,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

23.7M

Call Options Held

83.1K

Put Options Held

32.1K

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Citius Pharmaceuticals, Inc. Transaction History